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Letter to the Editor of European Journal of Pediatric Neurology regarding the manuscript “Single-center 
experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1” 
written by Pechmann and colleagues” 
A 5-center experience with intrathecal administration of Nusinersen in SMA1 in Italy 
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Dear Editor, 
We read with great interest the experience with intrathecal administration of Nusinersen in children with 
SMA1 reported by the Department of Neuropediatrics and Muscle Disorders from the University of 
Freiburg (1). The Authors describe the protocol applied at this single site giving details on the lumbar 
puncture procedure, sedation and monitoring during the procedure in 20 children with SMA1.  
They conclude that the lumbar puncture for intrathecal administration of Nusinersen can be performed 
without any relevant complications if a standard protocol is applied. This is important because while 
repetitive intrathecal administrations of drugs is relatively common in oncoematology in children, this 
treatment had never been applied to the neuromuscular field prior to Nusinersen. This is even more so in 
children with neuromuscular disorders having respiratory muscle weakness which makes them even more 
fragile and susceptible to respiratory complications during anesthesia if needed.  
 While we strongly agree with the suggestion that details on the procedure and on the protocol are 
important for others involved in the treatment of SMA, we also wish to highlight that the settings and some 
procedural details can be different in different centers according to what is available.   
As part of our experience  with the EAP (Expanded Access Program) in Italy  (1) Nusinsersen was 
administered intrathecally in over 120 children from December 2016 to December 2017.  Despite several 
commonalities (local anesthetic cream on the injection site, Quincke G22 needle, lateral decubitus position, 
video watching) there were site-specific differences  as each Center applied the protocol which best fitted 
the local setting and organization. (Table 1). Additional health-operators were involved during the 
procedure according to each site’s organization. 
Despite the different settings involved (eg surgery room vs out-patient clinic), types  of sedation and  
professionists performing the lumbar puncture, the procedure was succesfully performed in all centers but 
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in all the settings a multidisciplinary approach was needed.  While we agree  with the Authors’ conclusion 
that a standardized protocol can reduce the risks and feasibility limits of lumbar puncture in SMA1 children, 
we also strongly believe that this should be only performed in centres who have expertise in SMA and with 
a multidisciplinary setting. This information is relevant as Nusinersen is  becoming now commercially 
available in many countries  and some expertise  should be guaranteed in the centers who will be 
designated to perform the procedures.  
Table 1 
 The NEMO 
Clinical Center- 
Niguarda 
Hospital, Milan 
Istituto 
Giannina 
Gaslini, Genoa 
The NEMO 
Clinical Center-
Ospedale 
Gemelli, Rome 
Bambino Gesù 
Children’s 
Hospital, Rome 
The NEMO 
Clinical Center 
– Policlinico 
Universitario, 
Messina 
Setting for 
LP 
Surgery room Multifunctional 
room 
Pediatric 
Intensive Care 
Unit 
Pediatric Sub 
Intensive Care 
Unit 
Pediatric 
Intensive Care 
Unit  
Additional 
sedation 
used 
Nitrous oxide Nitrous oxide Sevorane gas Midazolam Midazolam 
Health-
operator 
performing 
LP 
Pediatrician or 
Neurologist or 
Child 
neurologist 
Child onco-
hematologist 
Anesthetician Pediatrician or 
Pediatric 
Neurologist 
Anesthetician 
Additional 
health-
operators 
during the 
procedure 
Respiratory 
physiotherapist 
Anesthetician as 
needed 
Nurse 
Nurse, 
Pediatrician, 
Pediatric 
neurologist 
Nurse, 
Pediatric 
neurologist,  
Respiratory 
physiotherapist 
Nurse, 
Pediatrician, 
Pediatric 
neurologist 
Nurse, 
Neurologist, 
Pyschologist 
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